Treatment of Advanced/Metastatic Melanoma in the United States and Western Europe: Results of the CancerMPact Survey
Stephanie Hawthorne, Linda Zhao, Madelyn Hanson, Gena Kanas, Christine Davis, David Robinson, Matthew Turnure, Otavio Clark Kantar, Health Division, New York, NY, USACorrespondence: Otavio ClarkKantar, 175 Greenwich St, WTC 3, 35th Floor, New York, NY 10007, USAEmail otavio.clark@kantar.comContext:...
Main Authors: | Hawthorne S, Zhao L, Hanson M, Kanas G, Davis C, Robinson D, Turnure M, Clark O |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2020-07-01
|
Series: | Cancer Management and Research |
Subjects: | |
Online Access: | https://www.dovepress.com/treatment-of-advancedmetastatic-melanoma-in-the-united-states-and-west-peer-reviewed-article-CMAR |
Similar Items
-
Decreased survival in patients treated by chemotherapy after targeted therapy compared to immunotherapy in metastatic melanoma
by: Marie‐Alix Mangin, et al.
Published: (2021-05-01) -
Preventative and Personalized Approach to the Treatment of Malignant Melanoma: A Case Report.
by: JD Matthew Hughes, et al.
Published: (2016-05-01) -
Update on use of aldesleukin for treatment of high-risk metastatic melanoma
by: Amaria RN, et al.
Published: (2015-04-01) -
Is there still a role for cytotoxic chemotherapy after targeted therapy and immunotherapy in metastatic melanoma? A case report and literature review
by: Aurélien Simon, et al.
Published: (2017-01-01) -
Efficacy and safety of anti-PD1 monotherapy or in combination with ipilimumab after BRAF/MEK inhibitors in patients with BRAF mutant metastatic melanoma
by: Ahmed, T., et al.
Published: (2022)